Stay updated on CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial page.

Latest updates to the CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial page
- Check2 days agoChange DetectedThe record history now includes a new revision entry labeled v3.6.5, replacing the previous v3.6.4, indicating an updated release of the study record metadata.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe Study Record Versions now show a new revision entry, v3.6.4, and the previous v3.6.3 entry is removed. This represents an administrative update to the page's history rather than a change to the trial data or user-visible content.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check38 days agoChange DetectedA new revision entry v3.6.3 was added to the study record history, replacing the previous v3.6.2. This reflects an update to the page's revision metadata and history tracking.SummaryDifference0.1%

- Check45 days agoChange DetectedA new revision entry v3.6.2 was added to the study record history, and the earlier revision v3.6.0 was removed from the list. This updates the visible version history to reflect the latest revision of the record.SummaryDifference0.1%

- Check59 days agoChange DetectedThe history view now displays a Last verified field and a new Revision: v3.6.0 tag, replacing the previous Verified/Last known status was indicators and older revision. This update reflects UI metadata and versioning information rather than changes to study data.SummaryDifference2%

- Check66 days agoChange DetectedA new revision entry v3.5.5 was added to the study history, replacing the previous v3.5.4. This reflects an update to the record's version history for the study.SummaryDifference0.1%

Stay in the know with updates to CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT053 Efficacy in Relapsed Multiple Myeloma Clinical Trial page.